DCF — NACOGDOCHES MEDICAL CENTER
Enterprise Value: $141.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$141.7M
Enterprise Value
$38.4M
PV of Cash Flows
$103.3M
PV of Terminal Value
$166.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $137.4M | $17.3M | 13.0% | $8.0M | $7.3M |
| Year 2 | $141.6M | $19.2M | 14.0% | $9.3M | $7.7M |
| Year 3 | $145.8M | $21.2M | 15.0% | $10.7M | $8.0M |
| Year 4 | $150.2M | $22.6M | 15.0% | $11.5M | $7.9M |
| Year 5 | $154.7M | $23.7M | 15.0% | $12.2M | $7.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $141.7M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$133.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.1205316722760868
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5